Frontiers Current Pharmacological Strategies for Duchenne

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Cell Therapy Strategies on Duchenne Muscular Dystrophy: A Systematic Review of Clinical Applications

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges - The Lancet Respiratory Medicine

PDF) Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Frontiers Treating Duchenne Muscular Dystrophy: The Promise of Stem Cells, Artificial Intelligence, and Multi-Omics

Role of CRISPR/Cas9 in the treatment of Duchenne muscular dystrophy and its delivery strategies - ScienceDirect

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Full article: Clinical development on the frontier: gene therapy for duchenne muscular dystrophy

Histone deacetylase inhibitors: a potential epigenetic treatment for Duchenne muscular dystrophy

PDF) Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies